55 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
28 Mar 24
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
8:00am
, Australia and global economies, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am
, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions and other business interruptions on our
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
16 Aug 23
Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
4:05pm
, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions and other business interruptions … including any adverse impacts on our ability to obtain raw materials and test animals as well as similar problems with our vendors and our current
424B5
i1vfwra7l0rw3wo
15 Jun 23
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.1
na2b9nw4v
15 May 23
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:00am
8-K
EX-99.1
37u599ll 4xi
24 Apr 23
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
8:13am
8-K
EX-99.1
iypd45y1o4wk
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
EX-99.1
5gire57 zol
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
8-K
EX-99.1
oay coq7t7
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
vq5bob
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
c7d6wpjuj464uag3pn3u
22 Dec 21
Regulation FD Disclosure
8:30am